Effects of heparin and aminoguanidine on glomerular basement membrane thickening in diabetic rats

APMIS

Volumn 104, Issue 4, 1996, Pages 259-264

  Oturai, Peter S ^a   Rasch, Ruth ^b   Hasselager, Erik ^c   Johansen, Peter B ^c   Yokoyama, Hiroki ^a   Thomsen, Mads K ^c   Myrup, Bjarne ^a   Kofoed Enevoldsen, Allan ^a   Deckert, Torsten ^a  

^a STENO DIABETES CENTER   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c NOVO NORDISK A S   (Denmark)

Author keywords

Aminoguanidine; Experimental diabetes; Glomerular basement membrane thickness; Heparin; Kidney tumours

Indexed keywords

AMINOGUANIDINE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029991518     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1996.tb00715.x     Document Type: Article

References (27)

1. Bangstad, H.-J., Østerby, R., Dahl-Jorgensen, K., Berg, K. J., Hartmann, A. & Hanssen, K. F.: Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 37: 483-490, 1994.
2. Brown, C. D., Zhao, Z. H., De Alvaro, F., Chan, S. & Friedman, E. A.: Correction of erythrocyte deformability defect in ALX-induced diabetic rabbits after treatment with aminoguanidine. Diabetes 42: 590-593, 1993.
3. Chavers, B. M., Bilous, R. W., Ellis, E. N., Steffes, M. W. & Mauer, S. M.: Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N. Engl. J. Med. 320: 966-970, 1989.
4. Diamond, J. R. & Karnovsky, M. J.: Nonanticoagulant protective effect of heparin in chronic aminonucleoside nephrosis. Renal Physiol. 9: 366-374, 1986.
5. Ellis, E. N. & Good, B. H.: Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus. Metabolism 40: 1016-1019, 1991.
6. Gambaro, G., Cavazzana, A. O., Luzi, P., Piccoli, A., Borsatti, A., Crepaldi, G., Marchi, E., Venturini, A. P. & Baggio, B.: Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int. 42: 285-291, 1992.
7. Gambaro, G., Venturini, A. P., Noonan, D. M., Fries, W., Re, G., Garbisa, S., Milanesi, C., Pesarini, A., Borsatti, A., Marchi, E. & Baggio, B.: Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney Int. 46: 797-806, 1994.
8. Hammes, H.-P., Martin, S., Federlin, K., Geisen, K. & Brownlee, M.: Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc. Natl. Acad. Sci. USA 88: 11555-11558, 1991.
9. Hiebert, L. M., Wice, S. M., McDuffie, N. M. & Jaques, L. B.: The heparin target organ - the endothelium. Studies in a rat model. Q. J. Med. 86: 341-348, 1993.
10. Ichikawa, I., Yoshida, Y., Fogo, A., Purkerson, M. L. & Klahr, S. : Effect of heparin on the glomerular structure and function of remnant nephrons. Kidney Int. 34: 638-644, 1988.
11. Jaques, L. B., Hiebert, L. M. & Wice, S. M.: Evidence from endothelium of gastric absorption of heparin and of dextran sulfates 8000. J. Lab. Clin. Med. 117: 122-130, 1991.
12. Jensen, E. B., Gundersen, H. J. G. & Østerby, R.: Determination of membrane thickness distribution from orthogonal intercepts. J. Microsc. 115: 19-33, 1979.
13. Kofoed-Enevoldsen, A.: Inhibition of glomerular glucosaminyl N-deacetylase in diabetic rats. Kidney Int. 41: 763-767, 1992.
14. Myrup, B., Hansen, P. M., Jensen, T., Kofoed-Enevoldsen, A., Feldt-Rasmussen, B., Gram, J., Kluft, C., Jespersen, J. & Decken, T.: Effect of low dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet 345: 421-422, 1995.
15. O'Brien, R., Cooper, M. E., Jerums, G. & Doyle, A. E.: The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy. Diabetes 42: 604-609, 1993.
16. O'Donnell, M. P., Kasiske, B. L. & Keane, W. F.: Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J. 2: 2339-2347, 1988.
17. Purkerson, M. L., Tollefsen, D. M. & Klahr, S.: N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation. J. Clin. Invest. 81: 69-74, 1988.
18. Rasch, R.: Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment: Glomerular basement membrane thickness. Diabetologia 16: 319-324, 1979.
19. Rasch, R.: Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment: Albumin excretion. Diabetologia 18: 413-416, 1980.
20. Soulis-Liparota, T., Cooper, M., Papazoglou, D., Clarke, B. & Jerums, G.: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rats. Diabetes 40: 1328-1334, 1991.
21. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977-986, 1993.
22. 125I-albumin permeation in retinas of chronically diabetic rats. Diabetes 41 (Suppl. 1): 21A, 1992.
23. Vasdev, S., Sampson, C. A., Longerich, L., Prabhakaran, V. M. & Parai, S.: Oral heparin normalizes blood pressure and elevated cytosolic calcium in hypertensive rats. Artery 19: 124-146, 1992.
24. Vasdev, S., Sampson, C. A., Longerich, L. & Parai, S.: Oral heparin prevents hypertension and elevated cytosolic calcium in salt-sensitive rats. Artery 19: 225-245, 1992.
25. Yokoyama, H., Myrup, B., Oturai, P. & Deckert, T.: Heparin, a possible therapy for diabetic complications: the effect on mesangial and myomedial cells in vivo and in vitro, especially with relation to extracellular matrix. J. Diabetes Complications 9: 97-103, 1995.
26. Zatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G. & Brenner, B. M.: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J. Clin. Invest. 77: 1925-1930, 1986.
27. Østerby, R.: Glomerular structural changes in Type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia 35: 803-812, 1992.